AAAAAA

   
Results: 1-8 |
Results: 8
Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines
Authors: Fischel, JL Rostagno, P Formento, P Dubreuil, A Etienne, MC Milano, G
Citation: Jl. Fischel et al., Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines, BR J CANC, 84(4), 2001, pp. 579-585
Enhanced antitumor activity of 5-fluorouracil in combination with 2 '-deoxyinosine in human colorectal cell lines and human colon tumor xenografts
Authors: Ciccolini, J Peillard, L Evrard, A Cuq, P Aubert, C Pelegrin, A Formento, P Milano, G Catalin, J
Citation: J. Ciccolini et al., Enhanced antitumor activity of 5-fluorouracil in combination with 2 '-deoxyinosine in human colorectal cell lines and human colon tumor xenografts, CLIN CANC R, 6(4), 2000, pp. 1529-1535
Impact of UFT on tumoral TS and DPD levels in colorectal cancer
Authors: Bastian, G Seitz, JF Moutardier, V Delperro, JR Fargeot, P Fraisse, J Formento, P Chazard, M Renee, N Milano, G
Citation: G. Bastian et al., Impact of UFT on tumoral TS and DPD levels in colorectal cancer, ONCOLOGY-NY, 14(10), 2000, pp. 35-37
Monitoring of the intracellular activation of 5-fluorouracil to deoxyribonucleotides in HT29 human colon cell line: application to modulation of metabolism and cytotoxicity study
Authors: Ciccolini, J Peillard, L Aubert, C Formento, P Milano, G Catalin, J
Citation: J. Ciccolini et al., Monitoring of the intracellular activation of 5-fluorouracil to deoxyribonucleotides in HT29 human colon cell line: application to modulation of metabolism and cytotoxicity study, FUN CL PHAR, 14(2), 2000, pp. 147-154
Time-schedule dependency of S 16020, a new topoisomerase II inhibitor
Authors: Soudon, J Milano, G Poullain, MG Fischel, JL Formento, P Berlion, M Giroux, B
Citation: J. Soudon et al., Time-schedule dependency of S 16020, a new topoisomerase II inhibitor, ANTI-CANC D, 10(6), 1999, pp. 597-604
Variable intrinsic sensitivity of human tumor cell lines to raltitrexed (Tomudex (R)) and folylpolyglutamate synthetase activity
Authors: Cheradame, S Chazal, M Fischel, JL Formento, P Renee, N Milano, G
Citation: S. Cheradame et al., Variable intrinsic sensitivity of human tumor cell lines to raltitrexed (Tomudex (R)) and folylpolyglutamate synthetase activity, ANTI-CANC D, 10(5), 1999, pp. 505-510
Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: an experimental study an human glioblastoma cell lines
Authors: Ilc, K Ferrero, JM Fischel, JL Formento, P Bryce, R Etienne, MC Milano, G
Citation: K. Ilc et al., Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: an experimental study an human glioblastoma cell lines, ANTI-CANC D, 10(4), 1999, pp. 413-417
A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil
Authors: Etienne, MC Pivot, X Formento, JL Bensadoun, RJ Formento, P Dassonville, O Francoual, M Poissonnet, G Fontana, X Schneider, M Demard, F Milano, G
Citation: Mc. Etienne et al., A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil, BR J CANC, 79(11-12), 1999, pp. 1864-1869
Risultati: 1-8 |